Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
18,346,444
-
Shares change
-
+2,157,199
-
Total reported value, excl. options
-
$170,228,516
-
Value change
-
+$20,289,375
-
Put/Call ratio
-
54%
-
Number of buys
-
40
-
Number of sells
-
28
-
Price
-
$9.28
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q1 2017
As of 31 Mar 2017 OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) had 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 18,346,444 shares of stock of the company.
Largest 10 holders included JENNISON ASSOCIATES LLC, Versant Venture Management, LLC, SV Health Investors, LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., COLUMBUS CIRCLE INVESTORS, VANGUARD GROUP INC, MORGAN STANLEY, and Opaleye Management Inc..
This table shows 73 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.